What about chemoprevention for melanoma?
- PMID: 16462188
- DOI: 10.1097/01.cco.0000208792.22442.d2
What about chemoprevention for melanoma?
Abstract
Purpose of review: This paper aims to critically review the potential for a chemoprevention strategy in melanoma, and to discuss new data on candidate chemoprevention agents, as chemoprevention has been suggested as an unexplored approach in melanoma.
Recent findings: A strong scientific rationale, established long-term safety of candidate agents, and a systematic step-wise approach to chemoprevention agent development are all critical for melanoma chemoprevention research. Among potential agents, the lipid-lowering drugs, the statins, satisfy these prerequisites.
Summary: Chemoprevention of cutaneous melanoma can become a valid strategy complementing current prevention approaches, as long as these important prerequisites are taken into consideration.
Similar articles
-
Cutaneous melanoma: pathogenesis and rationale for chemoprevention.Crit Rev Oncol Hematol. 2005 Mar;53(3):225-39. doi: 10.1016/j.critrevonc.2004.11.001. Crit Rev Oncol Hematol. 2005. PMID: 15718148 Review.
-
Chemoprevention of melanoma: theoretical and practical considerations.Cancer Control. 2005 Oct;12(4):219-22. doi: 10.1177/107327480501200402. Cancer Control. 2005. PMID: 16258492 Review.
-
Chemoprevention of melanoma: an unexplored strategy.J Clin Oncol. 2003 Jan 1;21(1):158-65. doi: 10.1200/JCO.2003.07.173. J Clin Oncol. 2003. PMID: 12506185 Review.
-
Developing agents for the therapeutic prevention of melanoma: can the assessment of cutaneous precursor lesions help?Future Oncol. 2020 Mar;16(9):413-415. doi: 10.2217/fon-2020-0012. Epub 2020 Feb 26. Future Oncol. 2020. PMID: 32100570 No abstract available.
-
Chemoprevention of skin cancer and photoaging.Clin Dermatol. 2004 May-Jun;22(3):178-82. doi: 10.1016/j.clindermatol.2003.12.012. Clin Dermatol. 2004. PMID: 15262302 Review.
Cited by
-
Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (-)-epigallocatechin-3-gallate (EGCG).Pharm Res. 2010 Jun;27(6):1103-14. doi: 10.1007/s11095-010-0054-5. Epub 2010 Mar 16. Pharm Res. 2010. PMID: 20232120
-
Peroxisome proliferator activated receptor α ligands as anticancer drugs targeting mitochondrial metabolism.Curr Pharm Biotechnol. 2013;14(3):342-56. doi: 10.2174/1389201011314030009. Curr Pharm Biotechnol. 2013. PMID: 21133850 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials